Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
Editorial
2011:77:6;631-639
doi: 10.4103/0378-6323.86469
PMID: 22016268

What's new in nail disorders?

Sunil Dogra, Savita Yadav
 Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Correspondence Address:
Sunil Dogra
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh-160 012
India
How to cite this article:
Dogra S, Yadav S. What's new in nail disorders?. Indian J Dermatol Venereol Leprol 2011;77:631-639
Copyright: (C)2011 Indian Journal of Dermatology, Venereology, and Leprology

Nails have a functional as well as aesthetic importance. Though it is a small structural and anatomical unit, it is affected by a variety of disorders. Major advances have occurred in skin and hair disorders at a fast pace over the last two decades. Nail has received little attention compared with other dermatological disorders. Nail disorders are rarely medically serious, but provide insight into various systemic disorders. Nail diseases can lead to impairment of hand function, difficulty in walking, and cosmetic disfigurement. This article provides an update on the status of nail disorders. We have reviewed the new nail disorders described recently and advances made in the diagnosis and therapy of nail disorders over the last few years.

New Entities Described

In this section, we present the recently described new nail disorders and reports of uncommon involvement of nail unit by common cutaneous dermatoses. We should be aware of these rare occurrences so that the diagnosis is not missed.

New disorders

Lateral ingrowth of nail plate or onychocryptosis is a well-known and studied nail disease process. Retronychia is a new entity occurring as a rare complication of onychomadesis. Retronychia stands for the proximal ingrowth of the nail plate into the nail matrix. Berker. et al[1] for the first time reported 19 patients of retronychia and the details of all the cases were presented and discussed at European Nail Society meeting (2007). The mean age of the patients was 39 years, with female preponderance (16/19). All the patients presented with complaints of proximal nail fold paronychia. The cardinal sign seen on examination was the elevation of the proximal nail plate beneath the proximal nail fold such that it was higher than the distal nail plate. In most of the patients, the nail showed yellowish discoloration due to the nail plate thickening. Granulation tissue was seen in the proximal nail fold in one-third of the cases and was most marked at the junction of the lateral and proximal nail folds. Big toe was affected in 16 of 19 subjects, whereas in three cases, hand was affected (thumb alone in two cases, thumb and index finger in one case). Around half of the patients reported an episode of trauma as the precipitating event.

Authors proposed that retronychia results due to the malalignment of the nail plate following its detachment from the matrix. The detached nail plate is pushed upward into the matrix and the new nail plate grows beneath it, further pushing the old nail plate upward. Subsequently, two to four new nail plates may get sandwiched beneath the old nail plate in the proximal nail fold. This malalignment most commonly occurs as a result of repeated distal trauma from the footwear which pushes the nail plate proximally and upward. Definitive treatment is the total nail plate avulsion which leads to subsidence of nail fold inflammation. The new nail plate growth is often normal and the recurrences are not seen as in lateral ingrowth of nail plate. Wortsman et al.[2] reported a case of triple finger retronychia resulting from trauma and the diagnosis was established using 3D ultrasonography (USG).

Worn down nail syndrome, also known as bidet nails, was first reported by Baran and Moulin. [3] They reported three unrelated women who had nail disorder characterized by a triangular defect of the fingernails with its base at the free edge of the nail. All these females had obsession for genital hygiene and nail changes were the result of excessive rubbing of nails against the porcelain of bidet while cleaning their genital area. Piraccini et al.[4] reported this nail disorder in 14 of their patients and Patrizi et al.[5] described it as a tic disorder in an 8-year-old girl child. The child had habit of scratching the school desk with his nails and finger tips. In this disorder, there is triangular thinning and erythema of the distal nail plate. On dermoscopy, dilated capillaries and pinpoint hemorrhage can be seen. Nails improve once the behavior is changed.

Lacquer nail described by Rigopoulos et al.[6] has significant overlap with worn down nail syndrome. Lacquer nail are the result of excessive rubbing of nail plate with nail filers provided with the topical antifungal nail lacquers.

Hair growth at ectopic sites like glans penis [7] and oral cavity [8] has been reported before. Onycotrychia has been recently described by Ferreira et al.[9] as a growth of hair follicle longitudinally underneath the nail plate. Their patient presented with single longitudinal brownish ridge of the right thumb nail plate evolving for last three months. The ridge started under the cuticle and in the distal third, it formed a hyperpigmented band. Nail biopsy revealed the presence of hair structure in the nail bed in contact with the nail plate. Immunocytochemistry with keratin 9 better defined the nail structure. Cerman [10] have reported onycotrychia in 16-month-old child as an isolated abnormality. Child presented with longitudinal black streak underneath the nail plate of second right toe. The nail plate was not affected unlike the case reported by Ferreira et al. Authors could not provide a satisfactory explanation for the occurrence of this anomaly.

Nail degloving was recently described by Baran and Perrin having three main clinical presentations and multiple etiologies. [11] First is the typical thimble-shaped nail shedding in which the walls of the thimble are composed of the skin of the distal digit including the nail plate (circumferential skin shedding). Second, a partially sloughed-off nail plate with its surrounding tissue composes nail degloving. In third presentation, shedding is restricted to the entire nail apparatus and its components (matrix, nail bed, hyponychium, and ventral aspect of the proximal nail fold) while the surrounding epidermis of the distal digit is spared. Various causes of nail degloving syndrome include trauma, toxic epidermal necrolysis, and digital gangrene. Lichen planus can rarely present with nail degloving type of involvement. [11]

Common disorders-uncommon site

Seborrheic keratosis (SKs) is a common benign epithelial cell tumor which commonly occurs in head and neck area and upper trunk. Bon-Mardion et al.[12] for the first time have reported SKs involving the nail bed. Their case was a 58-year-old man who had 1-year history of nail involvement in the form of longitudinal leukoxanthonychia. Dermoscopic examination showed longitudinal leukoxanthonychia with filiform hemorrhages and milia-like cysts. Histopathological examination revealed typical findings of SKs. So, SKs should be included in the differentials of leukoxanthonychia which includes squamous-cell carcinoma, subungual warts-induced lesion, onychomatricoma, and onychopapilloma.

Fixed drug eruption (FDE) is a common pattern of cutaneous drug reaction reported with a variety of drugs. Drug reaction occurs within 30 minutes to 8 hours of drug administration. The sites most commonly involved are mucosa and the limbs. Benton and McGibbon [13] have reported a case of FDE with amoxicillin-clavulanic acid in a 75-year-old man who presented with painful periungual and subungual erythema. On examination, circumscribed macules of erythema involving the paronychial fold and the nail bed were seen.

Pyogenic granuloma commonly involves the nail folds presenting as a bleeding exophytic growth. Rarely, it can present in the nail bed and then it has to be differentiated from amelanotic subungual melanoma. [14] There is a single report of subungual pyoderma gangrenosum. [15]

New Diagnostic in Nail

Diagnosis of nail disorders is based mainly on clinical examination, but some nail disorders need a further workup to establish the diagnosis and/or plan the treatment. Nail scraping is most commonly performed laboratory test in the clinical setting. Nail biopsies are occasionally done for the diagnosis of nail bed and matrix disorders but they are time consuming, unpleasant to the patient, and result in scarring and disfigurement of the nail. Nail apparatus has been deprived of investigative medical imaging until recently when there has been a growing interest in noninvasive techniques which could supplement the clinical examination of the nails. This includes USG, magnetic resonance imaging (MRI), optical coherence tomography (OCT), confocal laser scanning microscopy (CLSM), and improvised dermoscopy instruments.

Since onychomycosis (OM) is the most common nail disorder accounting for around 50% of total nail disease patients, [16] we have dealt with new advances in its diagnosis separately.

Advances in Medical Imaging of Nail

Ultrasound

Nail unit is well suited for USG study as it consists of well-defined tissues of different densities. [17] USG of nail requires a high-resolution ultrasound machines and high-frequency ultrasound probe. This modality is available since long time, but is finding place in the diagnosis of nail disorders only recently probably because of greater availability of machines with high resolution. USG is a good tool to diagnose cystic tumors of nail unit including myxoid cyst, synovial cyst, and collections like subungual hematoma or abscess. USG is not a good tool for the diagnosis of solid tumors like melanoma and squamous-cell carcinoma as they appear as nonspecific hypoechoic areas. [17]

Wortsman et al.[18] presented the ultrasonographic findings in retronychia nails in which the distance between the nail plate origin and distal interphalangeal (DIP) joint is reduced, proximal nail fold is thickened and hypoechoic, and sometimes multiple nail plates embedded into the proximal nail fold can be visualized.

Blood flow in the nail unit can be studied with color Doppler and power angio. These techniques are useful in the diagnosis of vascular tumors like glomus tumor. Imaging of vascular lesions can be further enhanced by means of using contrast media.

Newer technique called real-time compound spatial imaging is evolving. [19] It provides instantaneous integration of several overlapping ultrasound scans taken at different angles to produce a compound image with better information content.

Magnetic resonance imaging

High-resolution MRI provides an accurate analysis of the nail apparatus with detection of even 1 mm lesions. Use of MRI for nail disorders started in 1990s with the availability of small surface coils, mainly devoted to the diagnosis of glomus tumor. [20],[21] Nail unit tumors have atypical presentations as the lesion in nail matrix present with secondary nail plate changes and nail bed tumors are obscured by the nail plate. MRI has been used mainly for the diagnosis of nail unit tumors, glomus tumor being the commonest indication. Indications for MRI in relation to nail pathologies are still evolving. [22] Other indications include myxoid cyst, implantation epidermoid cyst, ganglion cyst onychomatricoma, exostosis, and osteochondromas.

Optical coherence tomography

OCT works in analogy to USG; the infrared light reflected from the skin is measured and the intensity is imaged as a function of position. The OCT probe is applied directly to the nail, scanning lasts for few seconds, and does not cause discomfort to the subject studied. This technique provides images of tissue pathology in situ with a high axial resolution. [23]

Mogensen et al.[24] found OCT technique to have low coefficients of variation compared with 20 Hz USG in measurements of nail plate thickness. Ayden et al.[25] recently reported OCT to provide higher resolution changes compared with nail USG in nail psoriasis. Abuzahra et al.[26] detected fungal elements noninvasively in vivo using OCT in 10 patients with histologically proven OM. Fungal elements were detectable as highly scattering elongated structures inside the nail plate, in the middle of the areas of homogeneous decrease in signal intensity.

Confocal laser scanning microscopy

CLSM is a new noninvasive diagnostic tool which is becoming increasingly popular. It can visualize cell structures of the skin up to a depth of 300 μm in vivo. It is based on the principal of increasing optical resolution and contrast of a micrograph by using point illumination and a spatial pinhole to eliminate out-of-focus light in specimens that are thicker than the focal plane. It also enables the reconstruction of three-dimensional structures from the obtained images. Researchers have found it to be faster and more accurate than the conventional microscope used in potassium hydroxide (KOH) preparations in the diagnosis of OM. [27],[28]

Dermatoscopy

Dermatoscopy is also known as dermoscopy and epiluminescence microscopy. It is the examination of skin using dermatoscope and is mainly used for distinguishing pigmented benign and malignant lesions. In nail unit, it is mainly used for patients presenting with melanonychia. Park et al.[29] have introduced a handy portable hand-held digital dermoscope (USB Microscope M2, Scalar Corporation, Tokyo, Japan) which can be used to study the nail fold capillary changes while sitting in a high-volume outpatient setting. It has the advantages of obtaining microscopic images on a computer monitor in real time; this makes the system more practical than other conventional dermoscopy systems using a camera that requires the development process. In addition, it has a polarizing light mode that minimizes the light reflection from the stratum corneum caused by the difference in the reflective index between the air and the stratum corneum. Thus, it does not require mineral oil or other immersion agents to reduce the light reflection.

Advances in Diagnosis of Onychomycosis

OM is a common problem, accounting for up to half of all diseases of the nail, with an estimated prevalence of 10% of the general population and approaching 60% in the elderly. [30],[31] Hay and Baran [32] have revised its classification because of the recognition of new pathways of nail infection, new pathogens and variations in the appearance of diseased infected nail.

KOH preparation and culture together have been considered as the gold standard test for OM diagnosis. [33] Nail sampling is done by means of curettage. In a study by Semer et al., [34] they compared sampling by means of nail drilling vis-a-vis curettage. They found that culture sensitivity was significantly higher when sampling was done by means of drilling technique as compared with conventional curettage technique. Direct microscopic examination using KOH preparation has low sensitivity. Fungal culture technique has high false-negative rate, requires long incubation period, risk of obscuration by bacterial overgrowth, and contamination with foreign material.

Periodic acid-Schiff (PAS) staining is a good diagnostic tool for the diagnosis of OM but probably less utilized by the dermatologist. Recently, it has been considered as the gold standard for the diagnosis of OM by some authors and is beginning to supplant KOH and culture in the diagnosis of OM. [35],[36] Wilsmann et al.[37] found histopathological staining to have highest sensitivity (82%), followed by culture (53%) and KOH preparation (48%). The results with PAS staining are faster compared with culture. It should be the preferred diagnostic tool, especially in cases where the diagnosis of OM is not certain and in those already on antifungal treatment.

Diagnosis of OM caused by non-dermatophyte molds is challenging, requiring more stringent criteria than that of dermatophytes. Based on the available data in literature, Gupta et al.[38] concluded that at the moment, traditional mycology remains the gold standard for diagnosing non-dermatophyte mold OM. This includes obtaining positive results from KOH and culture. Repeated isolations (2 or 3) in the absence of a dermatophyte increase the probability of accurate identification of the causative non-dermatophyte mold. Still, there is controversy over the number of inocula required to confirm the causative diagnosis. Histopathology can be of assistance in establishing the penetration of the non-dermatophyte mold into the nail plate; however, this method does not provide identification of the organism.

Development of newer techniques like polymerase chain reaction (PCR), [39] OCT, [26] flow cytometry, [40],[41] and immunohistochemistry [42] for the diagnosis of OM is underway. The routine use is impractical at present because of some limitations. Litz and Cavagnolo [39] have devised a quick inexpensive PCR test to detect dermatophyte DNA in nail specimens. They compared their PCR with KOH, fungal culture, and PAS staining. A total of 559 nail specimens were tested and PAS, PCR, KOH, and culture were positive in 54%, 37%, 40%, and 22% of specimens, respectively. PCR was negative in all non-dermatophyte and yeast isolates. PCR is specific, requires no morphologic expertise, has relatively good sensitivity, and gives faster results. This molecular approach is developing and with wider availability, it may prove to be a useful tool in future.

Other Advances in Nail Disorder Diagnosis

Nail biopsy is sometimes done to diagnose those conditions which are not clear on clinical examination or history alone. As nail is a highly vascular structure, bleeding from biopsy site is difficult to manage. Hwa et al.[43] reported easy control of post-biopsy bleeding using gelatin sponge saturated with aluminium chloride.

While doing nail procedures, digital block using plain lidocaine is the most common mode of administering anesthesia. Many authors have reported safe use of lidocaine-epinephrine mixture for digital block in good number of patients. [44],[45],[46] They did not observe digital necrosis in any of their patients, rather there were added advantages of combining with epinephrine. Epinephrine facilitates faster onset of anesthesia, prolonged post-procedure pain relief, and lesser amount of local anesthetic required without much need of tourniquet placement to control bleeding. So, lidocaine with epinephrine can be used for giving digital block, but caution should be exercised in patients with peripheral vascular diseases.

New Therapeutics in Nail

In this section, new advances are discussed in the management of OM, inflammatory disorders of nail, surgical treatment of nail disorders, and various other new approaches in the treatment of nail disorders.

New in onychomycosis treatment

OM is a common disorder caused by dermatophytes, non-dermatophyte molds, and yeasts. It is managed with topical and systemic antifungal therapy. At present, oral terbinafine is considered the treatment of choice for OM caused by dermatophytes. [47],[48] Ciclopirox and amorolfine are the two topical compounds used for mild to moderate OM or as an adjunct to systemic therapy. With standard therapies, response rate is less than 50%. [49] There is a continuing search for a convenient, cost-effective agent with high and long-lasting cure rates. Currently, many new therapies for OM are under investigation which includes new azoles, improvement of existing topical treatments through addition of ungual penetration enhancers and new topical drugs with better nail permeation. Several means to enhance ungual penetration are under investigation. [50] This includes the following:

  1. Physical enhancers - transungual laser therapy, electrokinetic transungual system iontophoretic application of terbinafine gel;
  2. Chemical enhancers - NM100060, econazole 5%/SEPA18% nail lacquer, nanoemulsion (NB-002), IDP-108, Ciclopoli™ 8% nail polish, AN-2690.

New triazole drugs (second generation triazoles) under trial for the treatment of OM include pramiconazole, posaconazole, ravuconazole, and albaconazole. [50] Voriconazole has high antifungal activity against dermatophytes as well as non-dermatophytes but its use is mainly directed to invasive fungal infections in immunocompromised individuals. Echinocandins and sordarins are two new groups of antifungals which are effective against azole-resistant fungi, but they are also under development for mainly invasive fungal infections.

Besides the topical and systemic medical therapy, investigators are devising new means of treatment of OM

  1. Photodynamic therapy (PDT) - Cases resistant to standard antifungal therapy and those who cannot take oral antifungals have been treated with photodynamic therapy. [51],[52],[53] Watanabe et al.[51] treated two with 20% solution of aminolevulinic acid (ALA) as photo sensitizer and irradiated with pulsed laser light at a wavelength of 630 nm at 100 J/cm 2 using an excimer-dye laser. Both the patient had complete clearance after 6 and 7 weekly sittings. Similar results have been reported by other authors. [52],[53]
  2. Dual wavelength device - uses optical energy for the treatment of OM. [54]
  3. Ultraviolet C (UVC) irradiation an in vitro study indicate that germicidal UVC irradiation may be a less invasive treatment option for onychomycosis, when the appropriate consideration is given to safety. [55]

These devices provide a non-drug approach and are undergoing testing for the treatment of OM.

With the currently available treatment options, recurrences are common occurring in 10 to 53% of cases. [56],[57] Sigurgeirsson et al.[58] studied the utility of topical amorolfine nail lacquer (ANL) for prevention of recurrence. The patients who were cured of confirmed OM were divided into two groups. One group applied ANL 2 weekly and the other group did not receive any treatment. Recurrence occurred more quickly in the untreated group and at end point, 70.8% remained cured in treated group, while 50% in the untreated group. Author concluded that ANL can serve as a good prophylactic tool to prevent recurrence of OM. However, in another long-term follow-up study, recurrence rate was not found to be related to presence of predisposing factors, use of nail lacquer as a prophylactic treatment, and the dermatophyte strain isolated. [59]

Non-dermatophyte OM is less common, incidence ranging from 1.45% to 17.6%. [60] Epidemiologically, the top five organisms in terms of published confirmed isolations worldwide are (in descending order) Scopulariopsis brevicaulis, Fusarium species, Aspergillus species, Scytalidium dimidiatum, and Acremonium species. [38] Non-dermatophyte show a poor response to topical as well as systemic antifungal therapy. Gupta et al[38] reviewed various studies on treatment of non-dermatophytes. Oral terbinafine and itraconazole have greatest amount of efficacy data. Both have shown efficacy in treating S. brevicaulis and Aspergillus species infections. A smaller amount of data supports the use of oral fluconazole and ketoconazole for treating S. brevicaulis. Griseofulvin should not be used for treating non-dermatophyte (NDM) OM. Topical ciclopirox may be effective in treating S. brevicaulis and Acremonium species infections. Systemic and/or topical therapy combined with periodic chemical or surgical nail debridement/avulsion may be the best option in the management of non-dermatophyte mold OM.

New in inflammatory disorders of nail

Treatment of nail psoriasis has received little attention compared with cutaneous psoriasis despite the significant burden it places on patients as a result of functional impairment of manual dexterity, pain, and psychological stress. Also, the treatment response of nail psoriasis is slow and incomplete. Sanchez-Regana et al.[61] retrospectively reviewed the data of 84 psoriasis patients who had received classical systemic therapy (acitretin, methotrexate, cyclosporin, photo (chemo) therapy) or biologics (infliximab, efalizumab, etanercept, adalimumab) for moderate to severe skin disease or psoriatic arthritis and had concomitant significant nail involvement. The author found that the NAPSI score fell significantly with all classical treatments (except NBUVB) as well as with the biological treatments. Among all the classical treatments, cyclosporine produced the highest improvement. In the biological treatment group, infliximab and adalimumab lead to significantly greater improvement at 12 and 24 weeks. The author did not find relation between response to treatment and type of nail involvement (matrix, bed, mixed). Also, the percentage of improvement in the NAPSI score was significantly greater with biological treatments compared with classical treatment.

Many new topical formulations and combinations have been tried for the treatment of nail psoriasis. [62],[63] Pulsed dye Laser (PDL) has been used to treat psoriatic plaques, and recently, PDL has been shown to improve nail psoriasis as well. [64]

Chronic paronychia is a common problem among the females which is multifactorial in origin. Initially, it was attributed to fungal infection primarily, but now the role of irritants and allergens in its development and propagation has been realized. Rigopoulos et al.[65] compared the response of chronic paronychia in 45 patients treated with tacrolimus or betamethasone-17-valereate or emollients. Treatment was given for three weeks and patients were followed up for further 6 weeks. Both betamethasone and tacrolimus groups achieved statistically significantly greater improvement when compared with the emollient group. This study stresses the importance of treatment with anti-inflammatory agents in addition to antifungal therapy in chronic paronychia patients.

New in surgical management of nail disorders

Ingrown toe nail, also known as onychocryptosis, is a common nail disorder. It is managed with either conservative approach or by surgical treatment, depending upon the clinical presentation and severity. Conservative approaches include antibiotics, silver nitrate cautery, proper nail trimming techniques, and flexible tube splinting (sleeve method). New non-surgical techniques using VHO-osthold nail brace, [66] resin splint, [67] super-elastic wire [68] have been described. All these techniques are based on same principle that is to keep the lateral nail plate pulled by making use of some equipment, so that it does not impinge into the lateral nail fold. Advantages of these techniques are that they are easy and faster to perform, good for elderly and diabetic individuals in whom surgery may otherwise be contraindicated, and lastly the nail anatomy remains unaltered. Disadvantages are that basic pathology is not corrected and recurrences can occur on removing the equipment, patient has to take care of device, and his activities may be limited because of it.

Ozdil et al. have described a new non-surgical procedure called angle correction technique in eight patients with ingrown toe nail. [69] The major principal of the technique is to correct the dome shape (convexity) of the nail by reducing its thickness 50 to 75%.

Different techniques of surgery for ingrown toe nail include Winograd method, whole nail plate avulsion, Emmert procedure, ablation of the nail matrix using phenol or sodium hydroxide or Lasers, and Zadik′s procedure. Payvandi et al.[70] compared Winograd and sleeve methods for the treatment of ingrown toe nails in 100 patients. They found that the participants treated with sleeve method experienced shorter surgery duration, less work day loss, and the recurrence rate were similar in two groups.

Pincer nail kind of deformity has been treated by nail plate avulsion followed by complete destruction of nail matrix by either chemical cautery or surgical matricectomy or laser. Ghaffarpour et al.[71] has described a new nail-saving surgical technique for correction of pincer nail deformity. The technique is a combination of nail bed cutting and splinting. First nail plate is removed, fibrous nail bed excised, and then widened. Remaining nail bed is sutured to the margins and then splint is applied, which ensure that the new nail growth is not deformed.

Glomus tumor has to be surgically excised. Roan et al.[72] have reported a new surgical approach for removing glomus tumor with nil recurrences and good cosmetic results. Author recommends cutting into the nail plate and nail bed over the tumor together without separating the nail plate from the nail bed. The tumor pops out when the nail plate and nail bed are split and then nail plate is sutured without the need of nail bed repair. This is easy to perform, gives good cosmetic results, and there were no recurrence in 17 reported patients.

Other Advances

Pachyonychia congenita (PC) is a rare autosomal-dominant keratin disorder caused by dominant negative mutations in keratin genes KRT6A/B, KRT16, or KRT17. It is characterized by painful plantar keratoderma and hypertrophic nail dystrophy. It is notoriously difficult to manage and systemic retinoids have been the main stay of therapy. But because of the rarity of the disorder, the optimum use of retinoids is not described. Gruber et al.[73] surveyed 30 patients of PC who had received oral retinoids (acitretin/isotretinoin 10-50 mg/day for 1-240 months). Nail changes ameliorated in 14% while 79% did not experience any nail change. In 50% cases, there was thinning of plantar hyperkeratosis and 33% had decreased plantar pain. Most of the patients (83%) discontinued retinoids because of the adverse effects. Risk benefit analysis favored low dose (≤25 mg/d) for longer period (>5 months) compared with higher dose (>25 mg/day) given for shorter period (≤5 months). The data indicate that acitretin may have a slight edge over isotretinoin in treating PC.

Sirolimus (rapamycin) is an mTOR inhibitor and mainly used presently in organ transplant recipient patients. Hickerson et al.[74] have treated keratinocyte cell line with mTOR inhibitors and this lead to decreased expression of K6a. Three PC patients given oral rapamycin had subjective improvement and change in callus character. Further research including topical formulations is warranted in this regard.

References
1.
de Berker DA, Richert B, Duhard E, Piraccini BM, André J, Baran R. Retronychia: Proximal ingrowing of the nail plate. J Am Acad Dermatol 2008;58:978-83.
[Google Scholar]
2.
Wortsman X, Calderon P, Baran R. Finger retronychias detected early by 3D ultrasound examination. J Eur Acad Dermatol Venereol 2011 May 30. [In Press]
[Google Scholar]
3.
Baran R, Moulin G. The bidet nail: A French variant of the worndown nail syndrome. Br J Dermatol 1999;140:377.
[Google Scholar]
4.
Piraccini BM, Tullo S, Iorizzo M, Rech G, Tosti A. Triangular worndown nails: Report of 14 cases. G Ital Dermatol Venereol 2005;140:161-4.
[Google Scholar]
5.
Patrizi A, Tabanelli M, Neri I, Pazzaglia M, Piraccini BM. Worn-down nail syndrome in a child. J Am Acad Dermatol 2008;59(2 Suppl 1):S45-6.
[Google Scholar]
6.
Rigopoulos D, Charissi C, Belyayeva-Karatza Y, Gregoriou S. Lacquer nail. J Eur Acad Dermatol Venereol 2006;20:1153-4.
[Google Scholar]
7.
Braun-Falco M, Köhn FM. Ectopic hair on the glans penis. Br J Dermatol 2005;153:218-9.
[Google Scholar]
8.
Agha-Hosseini F, Etesam F, Rohani B. A boy with oral hair: Case report. Med Oral Patol Oral Cir Bucal 2007;12:E357-9.
[Google Scholar]
9.
Ferreira O, Baudrier T, Mota A, Tellechea O, Cruz MJ, Guimarães M, et al. Onycotrychia?: Subungual hair follicle as another cause of longitudinal melanonychia or pigmentation -- hair follicle as cause of melanonychia. J Eur Acad Dermatol Venereol 2010;24:1238-40.
[Google Scholar]
10.
Cerman AA. Subungual ectopic hair. J Eur Acad Dermatol Venereol 2011;25:1115-6.
[Google Scholar]
11.
Baran R, Perrin C. Nail degloving, a polyetiologic condition with 3 main patterns: A new syndrome. J Am Acad Dermatol 2008;58:232-7.
[Google Scholar]
12.
Bon-Mardion M, Poulalhon N, Balme B, Thomas L. Ungualseborrheic keratosis. J Eur Acad Dermatol Venereol 2010;24:1102-4.
[Google Scholar]
13.
Benton EC, McGibbon D. Subungual fixed drug eruption. Br J Dermatol 2010;162:1397-8.
[Google Scholar]
14.
Piraccini BM, Bellavista S, Misciali C, Tosti A, de Berker D, Richert B. Periungual and subungual pyogenic granuloma. Br J Dermatol 2010;163:941-53.
[Google Scholar]
15.
Bashir SJ, McGibbon D. Subungual pyodermagangrenosum complicated by myopathy induced by ciclosporin and tacrolimus. Clin Exp Dermatol 2009;34:530-2.
[Google Scholar]
16.
Effendy I, Lecha M, Feuilhade de CM, Di Chiacchio N, Baran R; European Onychomycosis Observatory. Epidemiology and clinical classification of onychomycosis. J Eur Acad Dermatol Venereol 2005;19Suppl 1:8-12.
[Google Scholar]
17.
Wortsman X, Jemec GB. Ultrasound imaging of nails.Dermatol Clin 2006;24:323-8.
[Google Scholar]
18.
Wortsman X, Wortsman J, Guerrero R, Soto R, Baran R. Anatomical changes in retronychia and onychomadesis detected using ultrasound. Dermatol Surg 2010;36:1615-20.
[Google Scholar]
19.
Wortsman XC, Holm EA, Wulf HC, Jemec GB. Real-time spatial compound ultrasound imaging of skin. Skin Res Technol 2004;10:23-31.
[Google Scholar]
20.
Holzberg M. Glomus tumor of the nail: A 'redherring' clarified by magnetic resonance imaging. Arch Dermatol 1992;128:160-2.
[Google Scholar]
21.
Matloub HS, Muoneke VN, Prevel CD, Sanger JR, Yousif NJ. Glomus tumor imaging: Use of MRI for localization of occult lesions. J Hand Surg Am 1992;17:472-5.
[Google Scholar]
22.
Richert B, Baghaie M. Medical imaging and MRI in nail disorders: Report of 119 cases and review of literature. Dermatologic Ther 2002;15:159-64.
[Google Scholar]
23.
Pierce MC, Strasswimmer J, Park BH, Cense B, de Boer JF. Advances in optical coherence tomography imaging for dermatology. J Invest Dermatol 2004;123:458-63.
[Google Scholar]
24.
Mogensen M, Thomsen JB, Skovgaard LT, Jemec GB. Nail thickness measurements using optical coherence tomography and 20-MHz ultrasonography. Br J Dermatol 2007;157:894-900.
[Google Scholar]
25.
Aydin SZ, Ash Z, Del Galdo F, Marzo-Ortega H, Wakefield RJ, Emery P, et al. Optical coherence tomography: A new tool to assess nail disease in psoriasis? Dermatology 2011;222:311-3.
[Google Scholar]
26.
Abuzahra F, Spöler F, Först M, Brans R, Erdmann S, Merk HF, et al. Pilot study: Optical coherence tomography as a non-invasive diagnostic perspective for real time visualisation of onychomycosis. Mycoses 2010;53:334-9.
[Google Scholar]
27.
Kaufman G, Horwitz BA, Duek L, Ullman Y, Berdicevsky I. Infection stages of the dermatophyte pathogen Trichophyton: Microscopic characterization and proteolytic enzymes. Med Mycol 2007;45:149-55.
[Google Scholar]
28.
Hongcharu W, Dwyer P, Gonzalez S, Anderson RR. Confirmation of onychomycosis by in vivo confocal microscopy. J Am Acad Dermatol 2000;42:214-6.
[Google Scholar]
29.
Park JH, Lee DY, Cha HS, Koh EM. Handheld portable digital dermoscopy: Routine outpatient use for evaluating nail-fold capillary changes in autoimmune connective tissue diseases. J Eur Acad Dermatol Venereol 2009;23:207.
[Google Scholar]
30.
Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, et al. A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 2000;43:641-8.
[Google Scholar]
31.
Gupta AK, Jain HC, Lynde CW, Macdonald P, Cooper EA, Summerbell RC. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: A multicenter canadian survey of 15,000 patients. J Am Acad Dermatol 2000;43:244-8.
[Google Scholar]
32.
Hay RJ, Baran R. Onychomycosis: A proposed revision of the clinical classification. J Am Acad Dermatol 2011. [In Press]
[Google Scholar]
33.
Rajpar SF, Abdullah A. Management of onychomycosis and awareness of guidelines among dermatologists. Br J Dermatol 2006;155:1080-2.
[Google Scholar]
34.
Shemer A, Trau H, Davidovici B, Grunwald MH, Amichai B. Collection of fungi samples from nails: Comparative study of curettage and drilling techniques. J Eur Acad Dermatol Venereol 2008;22:182-5.
[Google Scholar]
35.
Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol 2003;49:193-7.
[Google Scholar]
36.
Reisberger EM, Abels C, Landthaler M, Szeimies RM. Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings. Br J Dermatol 2003;148:749-54.
[Google Scholar]
37.
Wilsmann-Theis D, Sareika F, Bieber T, Schmid-Wendtner MH, Wenzel J. New reasons for histopathologicalnail-clipping examination in the diagnosis of onychomycosis. J Eur Acad Dermatol Venereol 2011;25:235-7.
[Google Scholar]
38.
Gupta AK, Drummond-Main C, Cooper EA, Brintnell W, Piraccini BM, Tosti A. Systematic review of nondermatophyte mold onychomycosis: Diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol 2011. [In Press]
[Google Scholar]
39.
Litz CE, Cavagnolo RZ. Polymerase chain reaction in the diagnosis of onychomycosis: A large, single-institute study. Br J Dermatol 2010;163:511-4.
[Google Scholar]
40.
Kaya TI, Eskandari G, Guvenc U, Gunes G, Tursen U, Burak Cimen MY, et al. CD4+CD25+ Treg cells in patients with toenail onychomycosis. Arch Dermatol Res 2009;301:725-9.
[Google Scholar]
41.
Feuilhade de Chauvin M. New diagnostic techniques. J Eur Acad Dermatol Venereol 2005;19 (Suppl 1):20-4.
[Google Scholar]
42.
Arrese JE, Quatresooz P, Piérard-Franchimont C, Piérard GE. [Nail histomycology. Protean aspects of a human fungal bed].Ann Dermatol Venereol 2003;130:1254-9.
[Google Scholar]
43.
Hwa C, Kovich OI, Stein JA. Achieving hemostasis after nail biopsy using absorbable gelatin sponge saturated in aluminum chloride. Dermatol Surg 2011;37:368-9.
[Google Scholar]
44.
Altinyazar HC, Demirel CB, Koca R, Hosnuter M. Digital block with and without epinephrine during chemical matricectomy with phenol. Dermatol Surg 2010;36:1568-71.
[Google Scholar]
45.
Sonmez A, Yaman M, Ersoy B, Numanodlu A. Digital blocks with and without adrenalin: A randomised-controlled study of capillary blood parameters. J Hand Surg EurVol 2008;33:515-8.
[Google Scholar]
46.
Firoz B, Davis N, Goldberg LH. Local anesthesia using buffered 0.5% lidocaine with 1:200,000 epinephrine for tumors of the digits treated with Mohs micrographic surgery. J Am Acad Dermatol 2009;61:639-43.
[Google Scholar]
47.
Gianni C. Update on antifungal therapy with terbinafine. G Ital Dermatol Venereol 2010;145:415-24.
[Google Scholar]
48.
Finch JJ, Warshaw EM. Toenail onychomycosis: Current and future treatment options. Dermatol Ther 2007;20:31-46.
[Google Scholar]
49.
Epstein E. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data. Arch Dermatol 1998;134:1551-4.
[Google Scholar]
50.
Kumar S, Kimball AB. New antifungal therapies for the treatment of onychomycosis. Expert Opin Investig Drugs 2009;18:727-34.
[Google Scholar]
51.
Watanabe D, Kawamura C, Masuda Y, Akita Y, Tamada Y, Matsumoto Y. Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol 2008;144:19-21.
[Google Scholar]
52.
Sotiriou E, Koussidou-Eremonti T, Chaidemenos G, Apalla Z, Ioannides D. Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial. Acta Derm Venereol 2010;90:216-7.
[Google Scholar]
53.
Piraccini BM, Rech G, Tosti A. Photodynamic therapy of onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol 2008;59(5 Suppl):S75-6.
[Google Scholar]
54.
Landsman AS, Robbins AH, Angelini PF, Wu CC, Cook J, Oster M, et al. Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure. J Am Podiatr Med Assoc 2010;100:166-7.
[Google Scholar]
55.
Dai T, Tegos GP, Rolz-Cruz G, Cumbie WE, Hamblin MR. Ultraviolet C inactivation of dermatophytes: Implications for treatment of onychomycosis. Br J Dermatol 2008;158:1239-46.
[Google Scholar]
56.
Scher RK, Tavakkol A, Sigurgeirsson B, Hay RJ, Joseph WS, Tosti A, et al. Onychomycosis: Diagnosis and definition of cure. J Am Acad Dermatol 2007;56:939-44.
[Google Scholar]
57.
Gupta AK, Lynch LE. Onychomycosis: Review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence. Cutis 2004;74(1 Suppl):10-5.
[Google Scholar]
58.
Sigurgeirsson B, Olafsson JH, Steinsson JT, Kerrouche N, Sidou F.Efficacy of amrolfine nail lacquer for the prophylaxis of onychomycosis over 3 years. J Eur Acad Dermatol Venereol 2010;24:910-5.
[Google Scholar]
59.
Piraccini BM, Sisti A, Tosti A. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J Am Acad Dermatol 2010;62:411-4.
[Google Scholar]
60.
Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: Clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000;42:217-24.
[Google Scholar]
61.
Sánchez-Regaña M, Sola-Ortigosa J, Alsina-Gibert M, Vidal-Fernández M, Umbert-Millet P. Nail psoriasis: A retrospectivestudy on the effectiveness of systemic treatments (classical and biological therapy). J Eur Acad Dermatol Venereol 2011;25:579-86.
[Google Scholar]
62.
Sánchez Regaña M, MárquezBalbás G, Umbert Millet P. Nail psoriasis: A combined treatment with 8% clobetasolnail lacquer and tacalcitol ointment. J Eur Acad Dermatol Venereol 2008;22:963-9.
[Google Scholar]
63.
Cannavò SP, Guarneri F, Vaccaro M, Borgia F, Guarneri B. Treatment of psoriatic nails with topical cyclosporin: A prospective, randomized placebo-controlled study. Dermatology 2003;206:153-6.
[Google Scholar]
64.
Oram Y, Karincaoðlu Y, Koyuncu E, Kaharaman F. Pulsed dye laser in the treatment of nail psoriasis. Dermatol Surg 2010;36:377-81.
[Google Scholar]
65.
Rigopoulos D, Gregoriou S, Belyayeva E, Larios G, Kontochristopoulos G, Katsambas A. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: An unblinded randomized study. Br J Dermatol 2009;160:858-60.
[Google Scholar]
66.
Harrer J, Schöffl V, Hohenberger W, Schneider I. Treatment of ingrown toenails using a new conservative method: A prospective study comparing brace treatment with Emmert's procedure. J Am Podiatr Med Assoc 2005;95:542-9.
[Google Scholar]
67.
Matsumoto K, Hashimoto I, Nakanishi H, Kubo Y, Murao K, Arase S. Resin splint as a new conservative treatment for ingrown toenails. J Med Invest 2010;57:321-5.
[Google Scholar]
68.
Moriue T, Yoneda K, Moriue J, Matsuoka Y, Nakai K, Yokoi I, et al. A simple therapeutic strategy with super elastic wire for ingrown toenails. Dermatol Surg 2008;34:1729-32.
[Google Scholar]
69.
Ozdil B, Eray IC. New method alternative to surgery for ingrown nail: Angle correction technique. Dermatol Surg 2009;35:990-2.
[Google Scholar]
70.
Peyvandi H, Robati RM, Yegane RA, Hajinasrollah E, Toossi P, Peyvandi AA, et al. Comparison of two surgical methods (Winograd and sleeve method) in the treatment of ingrown toenail. Dermatol Surg 2011;37:331-5.
[Google Scholar]
71.
Ghaffarpour G, Tabaie SM, Ghaffarpour G. A new surgical technique for the correction of pincer-nail deformity: Combination of splint and nail bed cutting. Dermatol Surg 2010;36:2037-41.
[Google Scholar]
72.
Roan TL, Chen CK, Horng SY, Hsieh JH, Tai HC, Hsieh MH, et al. Surgical technique innovation for the excision of subungual glomus tumors. Dermatol Surg 2011;37:259-62.
[Google Scholar]
73.
Gruber R, Edlinger M, Kaspar RL, Hansen CD, Leachman S, Milstone LM, et al. An appraisal of oral retinoids in the treatment of pachyonychiacongenita. J Am Acad Dermatol 2011. [In Press]
[Google Scholar]
74.
Hickerson RP, Leake D, Pho LN, Leachman SA, Kaspar RL. Rapamycin selectively inhibits expression of an induciblekeratin (K6a) in human keratinocytes and improves symptoms in pachyonychiacongenita patients. J Dermatol Sci 2009;56:82-8.
[Google Scholar]
Show Sections